Apple's Earnings Report
Apple's First Annual Sales Decline in 15 Years
Apple reported its fourth quarter earnings yesterday, posting numbers that were roughly in line with analysts’ expectations. For the first time since 2001, the company wrapped up its fiscal year with lower sales than the year before. Apple’s revenue declined from $234 billion to $216 billion, mainly due to a whopping $18 billion decline in iPhone sales. The drop in sales of Apple’s flagship product isn’t as bad as it may sound though, because the previous year saw unusually high demand following the release of the company’s first iPhone models with a larger screen.
Even though analysts are fairly optimistic that Apple can return to growth this year, there are some tough pills to swallow for its shareholders. The company posted double-digit revenue declines across all major product categories, adding fuel to the argument that the company has lost its innovative edge and needs new products to continue growing in the mid- to long-term. The conference call following the earnings report gave a first impression of investors’ growing impatience: CEO Tim Cook was repeatedly pressed on the question of new products Apple may be working on, but as usual, Cook kept his answers vague and left the public clueless about anything his company may have up its sleeve.
- Annual sales percent change top pharmaceutical companies globally 2014-2015Annual sales percent change top pharmaceutical companies globally 2014-2015
- Annual sales revenue of the agency work industry worldwide 2002-2014Annual sales revenue of the agency work industry worldwide 2002-2014
- Zimmer Biomet's annual sales from 2011-2015, by product categoryZimmer Biomet's annual sales from 2011-2015, by product category
- Weekend box office revenue - March 2017Weekend box office revenue - March 2017
- Worldwide weekend box office revenue - March 2017Worldwide weekend box office revenue - March 2017
- GlaxoSmithKline's revenue 2006-2016GlaxoSmithKline's revenue 2006-2016
- GlaxoSmithKline's revenue by therapeutic area 2014-016GlaxoSmithKline's revenue by therapeutic area 2014-016
- GlaxoSmithKline's revenue by region 2012-2016GlaxoSmithKline's revenue by region 2012-2016
- Who may use the "Chart of the Day"?
- The Statista "Chart of the Day", made available under the Creative Commons License CC BY-ND 3.0, may be used and displayed without charge by all commercial and non-commercial websites. Use is, however, only permitted with proper attribution to Statista. When publishing one of these graphics, please include a backlink to the respective infographic URL.
- Which topics are covered by the "Chart of the Day"?
- The Statista "Chart of the Day" currently focuses on two sectors: "Media and Technology", updated daily and featuring the latest statistics from the media, internet, telecommunications and consumer electronics industries; and "Economy and Society", which current data from the United States and around the world relating to economic and political issues as well as sports and entertainment.
- Can Statista create customized charts?
Absolutely! For information on tailor-made and sector-specific
Charts of the Day, please contact Robin Hüdepohl